DERM - חוב כולל להון Journey Medical Corporation

Journey Medical (DERM) is a US-based company that develops and markets therapies for skin pathologies, leveraging established distribution channels and an existing portfolio of licensed products. However, the business faces pressure from low-cost generics, stringent FDA oversight, and a heavy reliance on marketing. This chart on GURU.Markets captures the 0.78 metric amid minimal geopolitical threats and a stable US legal environment.

Investors seek a balance between asset undervaluation and balance sheet resilience. This metric measures the proportion of borrowed funds relative to equity, determining the degree of financial leverage and bankruptcy risk. For Journey Medical (DERM), low indebtedness confirms the effective monetization of its proprietary dermatological drugs. The high margins of these unique medications allow the company to expand without excessive loans. Analyzing the debt-to-equity ratio helps identify the business's point of financial stability.